
Tevogen Bio CEO Emphasizes Dedication to Equity Capital Retention and Long-Term Vision
The Importance of Preserving Equity for Shareholders in Biotech Financing Ryan Saadi’s Commitment to Efficient and Profit-Focused Strategies WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving…